DCGI

DCGI approves Covishield and Covaxin for restricted emergency use in India

Read more

SEC recommends EUA for Covaxin from Bharat Biotech

Read more

SEC recommends EUA for Covishield, DCGI nod awaited

Read more

Awaiting India’s approval for COVISHIELD: SII 

Read more

Glenmark launches Remogliflozin + Vildagliptin FDC in India to treat Type 2 diabetes

Read more

AstraZeneca Pharma India gets DCGI nod for benralizumab injection, Fasenra

Read more

OPPI hosts Annual Summit, Healthcare Accelerated

Read more

Covishield can be available in first half of 2021

Read more

Gennova’s mRNA vaccine candidate for COVID-19 gets DCGI nod for human clinical trials

Read more

Serum Institute applies for EUA for Covishield in India

Read more